The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Altered glutathione redox state in schizophrenia.
Open accessAbstract
Altered antioxidant status has been reported in schizophrenia. The glutathione (GSH) redox system is important for reducing oxidative stress. GSH, a radical scavenger, is converted to oxidized glutathione (GSSG) through glutathione peroxidase (GPx), and converted back to GSH by glutathione reductase (GR). Measurements of GSH, GSSG and its related enzymatic reactions are thus important for evaluating the redox and antioxidant status. In the present study, levels of GSH, GSSG, GPx and GR were assessed in the caudate region of postmortem brains from schizophrenic patients and control subjects (with and without other psychiatric disorders). Significantly lower levels of GSH, GPx, and GR were found in schizophrenic group than in control groups without any psychiatric disorders. Concomitantly, a decreased GSH:GSSG ratio was also found in schizophrenic group. Moreover, both GSSG and GR levels were significantly and inversely correlated to age of schizophrenic patients, but not control subjects. No significant differences were found in any GSH redox measures between control subjects and individuals with other types of psychiatric disorders. There were, however, positive correlations between GSH and GPx, GSH and GR, as well as GPx and GR levels in control subjects without psychiatric disorders. These positive correlations suggest a dynamic state is kept in check during the redox coupling under normal conditions. By contrast, lack of such correlations in schizophrenia point to a disturbance of redox coupling mechanisms in the antioxidant defense system, possibly resulting from a decreased level of GSH as well as age‐related decreases of GSSG and GR activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Redox dysregulation has been observed in schizophrenic patients, who have defective antioxidant systems and exhibit increased lipid peroxidation (Do et al., 2000; Yao et al., 2006; Flatow et al., 2013).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Yao et al., 2006
In the citing paper
“Higher levels of oxidative stress have been reported in schizophrenia (Wang et al, 2009;Yao et al, 2006)”
From Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia (2016) · cites this paper as Yao et al, 2006
In the citing paper
“In an animal model with low GSH content, as reported in the brain of some schizophrenia patients (Do et al., 2000; Gawryluk et al., 2011; Yao et al., 2006), there is a deficit in prefrontal and hippocampal PVI, impairing high-frequency neuronal synchronization (Cabungcal et al., 2013a; Cabungcal et al., 2013b; Steullet et al., 2010).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Yao et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Free-Radical Chemistry of Cigarette Smoke and Its Toxicological Implications
CHURCH, D. F., & PRYOR, W. A. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.8564111 · Cited by 1,442
Selective Modification of Glutathione Metabolism
Meister, A. (1983) · Science · doi:10.1126/science.6836290 · Cited by 1,267 · cited 1×
“Its reducing and nucleophilic properties protect cells against destructive effects of reactive oxygen species and free radicals [12].”
Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitritea
Pryor, W. A., & Stone, K. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb39148.x · Cited by 1,179
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Glutathione: an overview of biosynthesis and modulation
Anderson, M. E. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00146-4 · Cited by 917
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540
Forman, H. J., Fukuto, J. M., & Torrès, M. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00516.2003 · Cited by 533
Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease
Rahman, I., & MacNee, W. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.6.l1067 · Cited by 420
Kinetics of Nitrosation of Thiols by Nitric Oxide in the Presence of Oxygen
Kharitonov, V. G., Sundquist, A. R., & Sharma, V. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28158 · Cited by 365
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 320
Inhibitory Interneurons, Oxidative Stress, and Schizophrenia
Sullivan, E. M., & O'Donnell, P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs052 · Cited by 71
Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 73
Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review
Arroll, M. A., Wilder, L., & James, N. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-91 · Cited by 70
Sydnor, V. J., & Roalf, D. R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.028 · Cited by 68
Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68
Reactive Oxygen Species: Angels and Demons in the Life of a Neuron
Biswas, K., Alexander, K. D., & Francis, M. M. (2022) · NeuroSci · doi:10.3390/neurosci3010011 · Cited by 74
A Defect in the Antioxidant Defense System in Schizophrenia
Vırıt, O., Altındağ, A., Yumru, M., Dalkiliç, A., SAVAS, H. A., Selek, Ş., Erel, Ö., & Herken, H. (2009) · Neuropsychobiology · doi:10.1159/000239684 · Cited by 63
Tane, A., Khalili‐Tanha, G., Esmaeili, A., Mobasheri, L., Kooshkaki, O., Jafari, S., Shokouhifar, A., & Sarab, G. A. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01401-0 · Cited by 63
Oxidative stress in bipolar and schizophrenia patients
Tunçel, Ö. K., Sarísoy, G., Bilgici, B., Pazvantoğlu, O., Çetin, E., Ünverdi, E., Avcı, B., & Böke, Ö. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.046 · Cited by 61
Choy, K. H. C., Dean, O. M., Berk, M., Bush, A. I., & van den Buuse, M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.035 · Cited by 62
Gysin, R., Kraftsik, R., Boulat, O., Bovet, P., Conus, P., Comte-Krieger, E., Polari, A. R., Steullet, P., Preisig, M., Bellier-Teichmann, T., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3463 · Cited by 62
Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia
Chowdari, K. V., Bamne, M. N., & Nimgaonkar, V. L. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3508 · Cited by 60
Alameda, L., Fournier, M., Khadimallah, I., Griffa, A., Cleusix, M., Jenni, R., Ferrari, C., Klauser, P., Baumann, P., Cuénod, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812821115 · Cited by 61
Redox Probing for Chemical Information of Oxidative Stress
Kim, E., Winkler, T. E., Kitchen, C., Kang, M., Banis, G., Bentley, W. E., Kelly, D. L., Reza Ghodssi, A., & Payne, G. F. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03620 · Cited by 57
Klauser, P., Xin, L., Fournier, M., Griffa, A., Cleusix, M., Jenni, R., Cuénod, M., Rolf Gruetter, A., Hagmann, P., Conus, P., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0266-8 · Cited by 61
Stojković, T., Radonjić, N. V., Velimirović, M., Jevtić, G., POPOVIC, V. M., Doknić, M., & Petronijević, N. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.013 · Cited by 53
Improvement of cognitive function in schizophrenia withN-acetylcysteine: A theoretical review
Yolland, C. O. B., Phillipou, A., Castle, D. J., Neill, E., Hughes, M. E., Galletly, C. A., Smith, Z. M., Francis, P. S., Dean, O. M., Sarris, J. J., et al. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1478766 · Cited by 52
Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia
Bousman, C., Luza, S., Mancuso, S. G., Kang, D., Opazo, C., Mostaid, M. S., Cropley, V., McGorry, P. D., Weickert, C. S., Pantelis, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38490-1 · Cited by 52
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Gardner, A., Chamielec, M., Orzechowska, A., Bobińska, K., & Kowalczyk, E. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1335-8 · Cited by 53
Advanced glycation end products and schizophrenia: A systematic review
Kouidrat, Y., Amad, A., Arai, M., Miyashita, M., Lalau, J., Loas, G., & Itokawa, M. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.023 · Cited by 51
Lagopoulos, J., Hermens, D. F., Tobias‐Webb, J., Duffy, S. L., Naismith, S. L., White, D., Scott, E. M., & Hickie, I. B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.12.006 · Cited by 51
Association of acute psychosocial stress with oxidative stress: Evidence from serum analysis
Kim, E., Zhao, Z., Rzasa, J. R., Glassman, M., Bentley, W. E., Chen, S., Kelly, D. L., & Payne, G. F. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102138 · Cited by 54
Impaired Metabolic Reactivity to Oxidative Stress in Early Psychosis Patients
Fournier, M., Ferrari, C., Baumann, P. S., Polari, A., Monin, A., Bellier-Teichmann, T., Wulff, J., Pappan, K. L., Cuenod, M., Conus, P., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu053 · Cited by 48
Zhang, J., Zhou, X. M., Wu, W., Wang, J., Xie, H., & Wu, Z. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.02.022 · Cited by 49
Sex-Specific Differences in Redox Homeostasis in Brain Norm and Disease
Ruszkiewicz, J. A., Miranda‐Vizuete, A., Tinkov, A. A., Геннадиевна, С. М., Skalny, A. V., Tsatsakis, A. M., & Aschner, M. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1241-9 · Cited by 47
Zhou, J., Coles, L. D., Kartha, R. V., Nash, N., Mishra, U., Lund, T. C., & Cloyd, J. C. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24482 · Cited by 47
Modeling autism: a systems biology approach
Randolph-Gips, M. M., & Srinivasan, P. N. (2012) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-2-17 · Cited by 49
Wang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46
Maintenance of glutathione levels and its importance in epigenetic regulation
GarcÃa-Giménez, J. L., & Pallardó, F. V. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00088 · Cited by 46
Cortical interneurons, immune factors and oxidative stress as early targets for schizophrenia
O’Donnell, P. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08130.x · Cited by 47
Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis
Berger, G. E., Smesny, S., Schäfer, M. R., Milleit, B., Langbein, K., Hipler, U., Milleit, C., Klier, C. M., Schlögelhofer, M., Holub, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148429 · Cited by 46
Calabrese, V., Giordano, J., Crupi, R., Paola, R. D., Ruggieri, M., Bianchini, R., Ontario, M. L., Cuzzocrea, S., & Calabrese, E. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23967 · Cited by 46
Redox Is a Global Biodevice Information Processing Modality
Kim, E., Li, J., Kang, M., Kelly, D. L., Chen, S., Napolitano, A., Panzella, L., Shi, X., Yan, K., Wu, S. Z., et al. (2019) · Proceedings of the IEEE · doi:10.1109/jproc.2019.2908582 · Cited by 47
Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
Palaniyappan, L. K., Park, M. T. M., Jeon, P., Limongi, R., Yang, K., Sawa, A., & Théberge, J. (2021) · Antioxidants · doi:10.3390/antiox10111703 · Cited by 58
Metabolomics in patients with psychosis: A systematic review
Li, C., Wang, A., Wang, C., Ramamurthy, J., Zhang, E. R., Guadagno, E., & Trakadis, Y. J. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32662 · Cited by 45
Phensy, A. J., Duzdabanian, H. E., Brewer, S. M., Panjabi, A., Driskill, C. M., Berz, A., Peng, G., & Kroener, S. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00106 · Cited by 45
Tran, T.-V., Shin, E., Jeong, J. H., Lee, J., Lee, Y., Jang, C., Nah, S.-Y., Lei, X. G., Toriumi, K., Yamada, K., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0239-y · Cited by 42
Nath, M., Vats, M., & Roy, P. (2015) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2015.03.023 · Cited by 41
Corcoba, A., Steullet, P., Duarte, J. M. N., van de Looij, Y., Monin, A., Cuénod, M., Rolf Gruetter, A., & Kim, Q. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv110 · Cited by 40
Nrf2 deficiency leads to behavioral, neurochemical and transcriptional changes in mice
Muramatsu, H., Katsuoka, F., Toide, K., Shimizu, Y. I., Furusako, S., & Yamamoto, M. P. (2013) · Genes to Cells · doi:10.1111/gtc.12083 · Cited by 40
Trivedi, M. S., Zhang, Y., López-Toledano, M. A., Clarke, A., & Deth, R. C. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.10.012 · Cited by 40
Retsa, C., Knebel, J., Geiser, E., Ferrari, C., Jenni, R., Fournier, M., Alameda, L., Baumann, P., Clarke, S., Conus, P., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.008 · Cited by 40
Al-Amin, M. M., Choudhury, M. F. R., Chowdhury, A. S., Chowdhury, T. R., Jain, P., Kazi, M., Alkholief, M. A., Alshehri, S., & Reza, H. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00384 · Cited by 42
Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients
Buosi, P., Borghi, F. A., Lopes, A. M., Facincani, I. S., Fernandes-Ferreira, R., Oliveira, C. I. F., Carmo, T. S., Souza, D. R. S., da Silva, D. G. H., de Almeida, E. A., et al. (2021) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2020-0078 · Cited by 40
Antioxidant Therapeutics for Schizophrenia
Reddy, R. D., & Reddy, R. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3571 · Cited by 40
Self-citationNath, M., Vats, M., & Roy, P. (2014) · Inorganica Chimica Acta · doi:10.1016/j.ica.2014.02.034 · Cited by 39
Progress in defining the biological causes of schizophrenia
Pickard, B. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001955 · Cited by 40
Anticarcinogenicity and Toxicity of Organotin(IV) Complexes: A Review
Ali, S., Shahzadi, S., & Din, I. U. (2016) · Iranian Journal of Science and Technology Transactions A Science · doi:10.1007/s40995-016-0048-1 · Cited by 38
Limongi, R., Jeon, P., Théberge, J., & Palaniyappan, L. K. (2021) · Antioxidants · doi:10.3390/antiox10010075 · Cited by 38
Owe‐Larsson, B., Ekdahl, K., Edbom, T., Ösby, U., Karlsson, H., Lundberg, C., & Lundberg, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.012 · Cited by 38
Cystamine prevents haloperidol‐induced decrease of BDNF/TrkB signaling in mouse frontal cortex
Pillai, A., Veeranan‐Karmegam, R., Dhandapani, K. M., & Mahadik, S. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05665.x · Cited by 38
Matsuzawa, D., Hashimoto, K., Hashimoto, T., Shimizu, E., Watanabe, H., Fujita, Y., & Iyo, M. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30776 · Cited by 37
Bošković, M., Vovk, T., Koprivšek, J., Plesničar, B. K., & Grabnar, I. (2014) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000139 · Cited by 37
Human dermal fibroblasts in psychiatry research
Kalman, J. L., Garbett, K. A., Janka, Z., & Mirnics, K. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.067 · Cited by 45
Smesny, S., Milleit, B., Schaefer, M. R., Hipler, U.-C., Milleit, C., Wiegand, C., Hesse, J., Klier, C. M., Holub, M., Holzer, I., et al. (2015) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.07.001 · Cited by 36
Andreazza, A. C. (2012) · Molecular BioSystems · doi:10.1039/c2mb25118c · Cited by 36
No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia
Ballesteros, A., Jiang, P. H., Summerfelt, A. T., Du, X. M., Chiappelli, J., O’Donnell, P., Kochunov, P., & Hong, L. E. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.001 · Cited by 36
Erythrocyte glutathione levels as long-term predictor of transition to psychosis
Lavoie, S., Berger, M., Schlögelhofer, M., Schäfer, M. R., Rice, S., Kim, S.-W., Hesse, J., McGorry, P. D., Smesny, S., & Amminger, G. P. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.30 · Cited by 35
Silva, T. D., Hafizi, S., Andreazza, A. C., Michael Kiang, A., Bagby, R. M., Navas, E., Laksono, I., Truong, P., Gerritsen, C. J., Prce, I., et al. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx094 · Cited by 35
Górny, M., Bilska‐Wilkosz, A., Iciek, M., Hereta, M., Kamińska, K., Kamińska, A., Chwatko, G., Rogóż, Z., & Lorenc‐Koci, E. (2020) · Antioxidants · doi:10.3390/antiox9060538 · Cited by 35
Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing?
Ansari, Z., Pawar, S. R., & Seetharaman, R. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.2006514 · Cited by 35
Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia
Ballesteros, A., Summerfelt, A., Du, X., Jiang, P., Chiappelli, J., Tagamets, M., O’Donnell, P., Kochunov, P., & Hong, L. E. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.05.021 · Cited by 34
Monte, A. S., da Silva, F. E. R., Lima, C. N. D. C., Vasconcelos, G. S., Gomes, N. S., Miyajima, F., Vasconcelos, S. M. M., Gama, C. S., Seeman, M. V., de Lucena, D. F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119875979 · Cited by 35
Arinola, G., Idonije, B. O., Akinlade, K. S., & Ihenyen, O. (2010) · Europe PMC (PubMed Central) · Cited by 34
Coughlin, J. M., Tanaka, T., Marsman, A., Wang, H., Bonekamp, S., Kim, P. K., Higgs, C., Varvaris, M., Edden, R. A. E., Pomper, M. G., et al. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303104811 · Cited by 35
A Multi-Center Study on Human Brain Glutathione Conformation using Magnetic Resonance Spectroscopy
Shukla, D., Mandal, P. K., Ersland, L., Grüner, E. R., Tripathi, M., Raghunathan, P., Sharma, A., Radhakrishna, C. G., Punjabi, K., & Splaine, C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180648 · Cited by 32
Poladian, N., Navasardyan, I., Narinyan, W., Orujyan, D., & Venketaraman, V. (2023) · Clinics and Practice · doi:10.3390/clinpract13040070 · Cited by 35
Ohnuma, T., & Arai, H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.027 · Cited by 31
Elevated plasma F2-isoprostane levels in schizophrenia
Lee, E., Eyler, L. T., Wolkowitz, O. M., Martin, A. S., Reuter, C., KRAEMER, H. C., & Jeste, D. V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.011 · Cited by 31
Early Life and Oxidative Stress in Psychiatric Disorders: What Can we Learn From Animal Models?
Mhillaj, E., Morgese, M. G., & Trabace, L. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150105122422 · Cited by 32
Thiol/disulfide homeostasis in untreated schizophrenia patients
Topçuoğlu, C., Bakirhan, A., Yılmaz, F. M., Neşeli̇oğlu, S., Erel, Ö., & Şahiner, Ş. Y. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.016 · Cited by 30
Gokhale, A., Vrailas‐Mortimer, A. D., Larimore, J. L., Comstra, H. S., Zlatic, S. A., Werner, E., Manvich, D. F., Iuvone, P. M., Weinshenker, D., & Faúndez, V. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv282 · Cited by 30
Porokhovnik, L. N., Passekov, V. P., Gorbachevskaya, N. L., Sorokin, A. B., Veiko, N. N., & Lyapunova, N. A. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000076 · Cited by 30
Michel, T. M., Sheldrick, A. J., Camara, S., Grünblatt, E., Schneider, F. W., & Riederer, P. F. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.526146 · Cited by 30
Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia
Yao, J. K., Condray, R., Dougherty, G. G., Keshavan, M. S., Montrose, D. M., Matson, W. R., McEvoy, J. P., Kaddurah-Daouk, R. F., & Reddy, R. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042165 · Cited by 29
Self-citationOxidative/Nitrosative Stress in Psychiatric Disorders: Are We There Yet?
O’Donnell, P., Do, K. Q., & Arango, C. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu048 · Cited by 29
Veselinović, T., & Neuner, I. (2022) · CNS Drugs · doi:10.1007/s40263-022-00935-z · Cited by 31
Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis
Yao, J. K., Dougherty, G. G., Reddy, R. D., Matson, W. R., Kaddurah-Daouk, R. F., & Keshavan, M. S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00090 · Cited by 28
Self-citationLangbein, K., Hesse, J., Gussew, A., Milleit, B., Lavoie, S., Amminger, G. P., Gaser, C., Wagner, G., Reichenbach, J. R., Hipler, U. ‐., et al. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.10.005 · Cited by 30
Redox proteomics and drug development
D’Alessandro, A., Rinalducci, S., & Zolla, L. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.01.001 · Cited by 27
Kartalcı, Ş., Karabulut, A. B., Özcan, C., Porgalı, E., & Ünal, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.05.007 · Cited by 27
Huang, T., Liou, C., & Lin, T. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.017 · Cited by 27
Wang, D., Sun, X., Maziade, M., Mao, W., Zhang, C., Wang, J., & Cao, B. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1769188 · Cited by 26
Cruz, B. F., de Campos-Carli, S. M., de Oliveira, A. M., de Brito, C. B., Garcia, Z. M., Arifa, R. D. D. N., Souza, D. G., Teixeira, A. L., & Salgado, J. V. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113832 · Cited by 28
Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia
Zhang, Y., Catts, V. S., & Weickert, C. S. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417728805 · Cited by 26
Adla, S. K., Virtanen, H., Thongsodsaeng, T., & Huttunen, K. M. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105771 · Cited by 27
Hafizi, S., Silva, T. M. S., Meyer, J. H., Kiang, M., Houle, S., Remington, G. J., Prce, I., Wilson, A. A., Rusjan, P., Sailasuta, N., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0061-5 · Cited by 25
Miljević, Č., Nikolić‐Kokić, A., Blagojević, D. P., Milovanović, M., Munjiza, A., Jukić, M. M., Pešić, V., Lečić‐Toševski, D., & Spasić, M. B. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.009 · Cited by 25
Steullet, P., Lavoie, S., Kraftsik, R., Guidi, R., Gysin, R., Cuenod, M., & Do, K. (2008) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2007.12.006 · Cited by 29
Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review
Chung, J. K., Nakajima, S., Plitman, E., Iwata, Y., Uy, D., Gerretsen, P., Caravaggio, F., Chakravarty, M. M., & Graff‐Guerrero, A. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.03.013 · Cited by 24
Subcortical brain iron deposition in individuals with schizophrenia
Sonnenschein, S. F., Parr, A. C., Larsen, B., Calabro, F. J., Foran, W., Eack, S. M., Luna, B., & Sarpal, D. K. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.04.013 · Cited by 24
Górny, M., Wnuk, A., Kamińska, A., Kamińska, K., Chwatko, G., Bilska‐Wilkosz, A., Iciek, M., Kajta, M., Rogóż, Z., & Lorenc‐Koci, E. (2019) · Molecules · doi:10.3390/molecules24234253 · Cited by 24
Lavoie, S., Allaman, I., Petit, J.-M., Kim, Q., & Magistretti, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022875 · Cited by 23
Redox Dysregulation in Schizophrenia: Genetic Susceptibility and Pathophysiological Mechanisms
Do, K. Q., Bovet, P., Cabungcal, J.-H., Conus, P., Gysin, R., Lavoie, S., Steullet, P., & Cuénod, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_8 · Cited by 22
Neuroprotection in Schizophrenia and Its Therapeutic Implications
Kim, Y., & Na, K. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.4.383 · Cited by 22
Nichenametla, S. N., Ellison, I., Calcagnotto, A., Lazarus, P. J., Muscat, J. E., & Richie, J. P. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.012 · Cited by 22
Glutathione Conformations and Its Implications for in vivo Magnetic Resonance Spectroscopy
Mandal, P. K., Shukla, D., Govind, V., Boulard, Y., & Ersland, L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170350 · Cited by 22
Schmidt, A. J., Hemmeter, U., Krieg, J.-C., Vedder, H., & Heiser, P. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.005 · Cited by 22
Терешкина, Е. Б., Savushkina, O. K., Бокша, И. С., Prokhorova, T. A., Vorobyeva, E. A., Omelchenko, M. A., Николаевич, П. А., Каледа, В. Г., & Burbaeva, G. S. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911902161 · Cited by 26
Validation of oxidative stress assay for schizophrenia
Kim, E., Keskey, Z., Kang, M., Kitchen, C., Bentley, W. E., Chen, S., Kelly, D. L., & Payne, G. F. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.057 · Cited by 21
Metadata
- Authors
- Yao, J. K., Leonard, S., & Reddy, R.
- Affiliations
- University of Pittsburgh (US)
- Denver VA Medical Center (US)
- VA Pittsburgh Healthcare System (US)
- Corresponding author
- Yao, Jeffrey K.
- ORCID
- Reddy, Ravinder
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 22
- Issue
- 1-2
- Pages
- 83-93
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- PMC
- PMC3850558
- OpenAlex
- W2088215062
- Cited by
- 321
- References
- 45
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 20 · 2021: 20 · 2020: 10 · 2019: 16 · 2018: 19 · 2017: 18 · 2016: 18 · 2015: 21 · 2014: 12 · 2013: 18 · 2012: 21
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Disease Markers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH58141, MH64118, DA09457)
- Brain and Behavior Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- schizophrenia, glutathione, glutathione disulfide, glutathione peroxidase, glutathione reductase, GSH/GSSG ratio, oxidative stress, antioxidant defense, redox coupling, caudate nucleus, postmortem brain, age-related decline
- MeSH terms
- Age Factors, Aged, Caudate Nucleus, Female, Glutathione, Glutathione Reductase, Humans, Male, Middle Aged, Oxidation-Reduction, Schizophrenia, Sex Factors, Smoking, Glutathione Disulfide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
